Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Affimed Announces Positive Early Efficacy and Progression Free Survival Results of AFM24-102 Study in EGFR Wild-Type Non-Small Cell Lung Cancer at the Annual Meeting of the American Society of Clinica
-
Cullinan Therapeutics to Present First Data for CLN-619, a Novel Anti-MICA/B Antibody, in Combination with a Checkpoint Inhibitor and Updated Monotherapy Data at ASCO 2024
-
Promising Anti-tumor Activity of Novel Costimulatory Bispecific Antibody REGN7075 (EGFRxCD28) in Combination with Libtayo® (cemiplimab) to be Reported at ASCO
-
Zentalis Pharmaceuticals to Present Promising Results from Phase 1 Trial of Azenosertib and Gemcitabine in Relapsed or Refractory Osteosarcoma at 2024 American Society of Clinical Oncology Annual Meet
-
Cogent Biosciences Announces Positive Updated Lead-In Data from Ongoing Phase 3 PEAK Trial Evaluating Bezuclastinib in Combination with Sunitinib in Patients with Gastrointestinal Stromal Tumors (GIST
-
HOOKIPA Pharma Announces Positive Clinical Data to be Presented at the American Society for Clinical Oncology 2024 Annual Meeting
-
Timbercreek Financial Declares May 2024 Dividend
-
Arvinas Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Congress
-
Canadian Premium Sand Inc. Announces Second Quarter 2024 Results
-
Werewolf Therapeutics to Present Updated Data from Phase 1/1b Clinical Trial of WTX-124 as Monotherapy and in Combination with Pembrolizumab in Solid Tumors at 2024 ASCO Annual Meeting
-
Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual Meeting
-
Replimune to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
-
Theratechnologies’ Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors
-
Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual Meeting
-
Merus Announces Publication of Abstracts for Presentation at the 2024 ASCO® Annual Meeting
-
MAQUIA CAPITAL ACQUISITION CORPORATION AND IMMERSED INC. MUTUALLY AGREE TO TERMINATE BUSINESS COMBINATION AGREEMENT
-
Merus Announces Publication of an Abstract on Petosemtamab with Pembrolizumab as 1L treatment of r/m HNSCC at the 2024 ASCO® Annual Meeting
-
Candel Therapeutics Reports Prolonged Overall Survival in Phase 2 Clinical Trial of CAN-2409 for Advanced Non-Small Cell Lung Cancer (NSCLC) in Patients Non-Responsive to Immune Checkpoint Inhibitor (
-
Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology Annual Meeting
-
Kymera Therapeutics to Present New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at ASCO Annual Meeting
-
IN8bio Announces INB-200 Phase 1 Study Data in Newly Diagnosed Glioblastoma to be Presented at the 2024 ASCO Annual Meeting
-
Tizona Therapeutics Presents Phase 1b TTX-080 Clinical Data in Advanced Colorectal Cancer and Head and Neck Squamous Cell Carcinoma at ASCO 2024
-
Evaxion to Present New Positive Data from Ongoing Phase 2 Study on Lead Vaccine Candidate EVX-01 at the American Society of Clinical Oncology Annual Meeting 2024
-
NVIDIA Announces Upcoming Event for Financial Community
-
Genmab to Showcase Data in Various Patient Populations to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting
-
Park Aerospace Corp. Announces Date of Fiscal Year Earnings Release and Conference Call
-
THOR Industries Announces Date For Its Fiscal 2024 Third Quarter Earnings Release
-
Acme United Corporation Acquires the Assets of Elite First Aid
-
ValueZone Strengthens Resources for Traders in Current Bull Market
-
HUB Security Provides an Update on the 2023 Annual Report
-
Philips successfully prices offering of Notes for EUR 700 million to be used for repayment of existing debt
-
Red River Bancshares, Inc. Announces Quarterly Cash Dividend
-
Interpublic Declares Common Stock Dividend
-
Dime Hires Judy Wu as Executive Vice President, General Counsel and Corporate Secretary
-
Millicom (Tigo) comments on shareholder communication
-
Lilium Announces Launch of Offering of Class A Shares and Warrants
-
Clearwave Fiber Launches Inaugural Salute to Service Program
-
Quanex Building Products Declares Quarterly Dividend
-
Genco Shipping & Trading Shareholders Overwhelmingly Re-Elect All Genco Director Nominees at the 2024 Annual Meeting
-
SiriusPoint Announces Jim McKinney as Chief Financial Officer
-
Genco Shipping & Trading Shareholders Overwhelmingly Re-Elect All Genco Director Nominees at the 2024 Annual Meeting
-
Kane Biotech Announces First Quarter 2024 Financial Results
-
Stifel Reports April 2024 Operating Data
-
Concrete Pumping Holdings Sets Second Quarter 2024 Earnings Conference Call for Thursday, June 6, 2024
-
Inotiv, Inc. to Participate in Upcoming Craig Hallum and Jefferies Investor Conferences
-
Navient declares second quarter common stock dividend
-
CooperCompanies’ 2023 Environmental, Social, and Governance Report Highlights Efforts that Benefit People and the Planet
-
NANOBIOTIX to Present at the Jefferies Global Healthcare Conference
-
Quanex Building Products Announces Second Quarter 2024 Earnings Release and Conference Call Schedule
-
VALHI ANNOUNCES QUARTERLY CASH DIVIDEND AND RESULTS OF ANNUAL STOCKHOLDER MEETING

